Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Integrated Analysis Reveals the Gut Microbial Metabolite TMAO Promotes Inflammatory Hepatocellular Carcinoma by Upregulating POSTN
Yonglin Wu, Xingyu Rong, Miaomiao Pan, et al.
Frontiers in Cell and Developmental Biology (2022) Vol. 10
Open Access | Times Cited: 20

Showing 20 citing articles:

Gut-liver axis: Pathophysiological concepts and medical perspective in chronic liver diseases
Susana Rodrigues, Van der Merwe, Aleksander Krag, et al.
Seminars in Immunology (2024) Vol. 71, pp. 101859-101859
Open Access | Times Cited: 19
The gut microbiota derived metabolite trimethylamine N-oxide: Its important role in cancer and other diseases
Yuhua Zhou, Yuwei Zhang, Shengkai Jin, et al.
Biomedicine & Pharmacotherapy (2024) Vol. 177, pp. 117031-117031
Open Access | Times Cited: 11
Gut microbiota derived metabolite trimethylamine N-oxide influences prostate cancer progression via the p38/HMOX1 pathway
Yuhua Zhou, Jing Lv, Shengkai Jin, et al.
Frontiers in Pharmacology (2025) Vol. 15
Open Access | Times Cited: 1
Role of Gut Microbial Metabolites in the Pathogenesis of Primary Liver Cancers
Maria Pallozzi, Valeria De Gaetano, Natalia Di Tommaso, et al.
Nutrients (2024) Vol. 16, Iss. 14, pp. 2372-2372
Open Access | Times Cited: 7
Microbial metabolites affect tumor progression, immunity and therapy prediction by reshaping the tumor microenvironment (Review)
Yuhang Zhou, Wenjie Han, Yun Feng, et al.
International Journal of Oncology (2024) Vol. 65, Iss. 1
Open Access | Times Cited: 6
Manipulating the Gut Microbiome to Alleviate Steatotic Liver Disease: Current Progress and Challenges
E. Sáenz, Nathally Espinosa Montagut, Baohong Wang, et al.
Engineering (2024) Vol. 40, pp. 51-60
Open Access | Times Cited: 4
Proline/serine-rich coiled-coil protein 1 alleviates pyroptosis in murine bone marrow-derived macrophages
Qiao Wu, Qianqian Wang, Kexin Hu, et al.
Acta Biochimica et Biophysica Sinica (2025)
Open Access
The interplay between gut bacteria and targeted therapies: implications for future cancer treatments
Juan He, Yu Chen, Huakan Zhao, et al.
Molecular Medicine (2025) Vol. 31, Iss. 1
Open Access
Oxidative stress bridges the gut microbiota and the occurrence of frailty syndrome
Si-Yue Chen, Tong-Yao Wang, Chao Zhao, et al.
World Journal of Gastroenterology (2022) Vol. 28, Iss. 38, pp. 5547-5556
Open Access | Times Cited: 17
Antioxidant Role of Probiotics in Inflammation-Induced Colorectal Cancer
Sevag Hamamah, Andrei Lobiuc, Mihai Covașă
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 16, pp. 9026-9026
Open Access | Times Cited: 3
Trimethylamine N-oxide promotes the proliferation and migration of hepatocellular carcinoma cell through the MAPK pathway
Chunfang Zhou, Rina Basnet, Chenxiang Zhen, et al.
Discover Oncology (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 3
High-throughput metabolomics identifies new biomarkers for cervical cancer
Xue Li, Li-Yi Zhang, Xuan Huang, et al.
Discover Oncology (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 2
The gut microbiota – A vehicle for the prevention and treatment of hepatocellular carcinoma
Diren Beyoğlu, Jeffrey R. Idle
Biochemical Pharmacology (2022) Vol. 204, pp. 115225-115225
Closed Access | Times Cited: 10
Intestinal microbiota: A bridge between intermittent fasting and tumors
Jing Liu, Nan Shao, Hui Qiu, et al.
Biomedicine & Pharmacotherapy (2023) Vol. 167, pp. 115484-115484
Open Access | Times Cited: 5
Investigating the Influence of Gut Microbiota-related Metabolites in Gastrointestinal Cancer
Zeynab Marzhoseyni, Zahra Shaghaghi, Maryam Alvandi, et al.
Current Cancer Drug Targets (2024) Vol. 24, Iss. 6, pp. 612-628
Closed Access | Times Cited: 1
Therapeutic manipulation of the microbiome in liver disease
Gopanandan Parthasarathy, Harmeet Malhi, Jasmohan S. Bajaj
Hepatology (2024)
Closed Access | Times Cited: 1
Nutrition and Microbiome Interactions in Human Cancer
Phillip J. Daschner, Sharon E. Taverno Ross, Harold E. Seifried, et al.
Journal of the Academy of Nutrition and Dietetics (2022) Vol. 123, Iss. 3, pp. 504-514
Closed Access | Times Cited: 7
The Emerging Role of the Microbiome in Carcinogenesis
Travis J Gates, Matthew Dietz, Marı́a Martell, et al.
Elsevier eBooks (2024)
Closed Access
Molecular mechanisms of metabolic disease-associated hepatic inflammation in non-alcoholic fatty liver disease and non-alcoholic steatohepatitis
Chunye Zhang, Yuxiang Sui, Shuai Liu, et al.
(2023), pp. 246-275
Open Access | Times Cited: 1
Analysis of Immune-Related and Angiogenesis-Related Genes in Hepatocellular Carcinoma: Implications for Prognosis and Drug Sensitivity
Peng Wang, Haoran Zhao, chunxun liu, et al.
Research Square (Research Square) (2023)
Open Access
Page 1

Scroll to top